CY2022030I2 - Μειγματα αναλογων κυκλοσπορινης και η χρηση τους ως ανοσορρυθμιστικοι παραγοντες - Google Patents

Μειγματα αναλογων κυκλοσπορινης και η χρηση τους ως ανοσορρυθμιστικοι παραγοντες

Info

Publication number: CY2022030I2
Authority: CY; Cyprus
Prior art keywords: immunosuppressors; mixtures; cyclosporine analogues; cyclosporine; analogues
Prior art date: 2001-10-19

Application number

CY2022030C

Other languages

English (en)

Other versions

CY2022030I1 (el

Original Assignee

Aurinia Pharmaceuticals Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-19

Filing date

2022-10-14

Publication date

2023-06-09

2022-10-14 Application filed by Aurinia Pharmaceuticals Inc. filed Critical Aurinia Pharmaceuticals Inc.

2023-01-27 Publication of CY2022030I1 publication Critical patent/CY2022030I1/el

2023-06-09 Publication of CY2022030I2 publication Critical patent/CY2022030I2/el

Links

PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical class CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C07K7/645—Cyclosporins; Related peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Dermatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Hematology (AREA)
Pulmonology (AREA)
Neurology (AREA)
Rheumatology (AREA)
Dispersion Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Neurosurgery (AREA)
Virology (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)

CY2022030C 2001-10-19 2022-10-14 Μειγματα αναλογων κυκλοσπορινης και η χρηση τους ως ανοσορρυθμιστικοι παραγοντες CY2022030I2 (el)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US34620101P	2001-10-19	2001-10-19
PCT/CA2002/001560 WO2003033527A2 (en)	2001-10-19	2002-10-17	Cyclosporine analogue mixtures and their use as immunomodulating agents

Publications (2)

Publication Number	Publication Date
CY2022030I1 CY2022030I1 (el)	2023-01-27
CY2022030I2 true CY2022030I2 (el)	2023-06-09

Family

ID=23358378

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
CY20081101130T CY1108410T1 (el)	2001-10-19	2008-10-13	Μειγματα αναλογων κυκλοσπορινης και η χρηση τους ως ανοσορυθμιστικοι παραγοντες
CY2022030C CY2022030I2 (el)	2001-10-19	2022-10-14	Μειγματα αναλογων κυκλοσπορινης και η χρηση τους ως ανοσορρυθμιστικοι παραγοντες

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
CY20081101130T CY1108410T1 (el)	2001-10-19	2008-10-13	Μειγματα αναλογων κυκλοσπορινης και η χρηση τους ως ανοσορυθμιστικοι παραγοντες

Country Status (38)

Country	Link
US (2)	US20110092669A1 (el)
EP (2)	EP1816138A1 (el)
JP (4)	JP2005511538A (el)
KR (1)	KR100992850B1 (el)
CN (1)	CN100344648C (el)
AR (1)	AR036853A1 (el)
AT (1)	ATE401339T1 (el)
AU (1)	AU2002331510B2 (el)
BE (1)	BE2022C547I2 (el)
BR (1)	BR0213659A (el)
CA (2)	CA2727642C (el)
CO (1)	CO5570682A2 (el)
CY (2)	CY1108410T1 (el)
DE (1)	DE60227686D1 (el)
DK (1)	DK1436322T3 (el)
EC (3)	ECSP045061A (el)
ES (1)	ES2310604T3 (el)
FI (1)	FIC20220041I1 (el)
FR (1)	FR22C1051I2 (el)
HK (1)	HK1062567A1 (el)
HR (1)	HRP20040353B1 (el)
IL (2)	IL160762A0 (el)
LT (1)	LTC1436322I2 (el)
MA (1)	MA26337A1 (el)
ME (1)	ME00487B (el)
MX (1)	MXPA04003624A (el)
MY (1)	MY187182A (el)
NL (1)	NL301200I2 (el)
NO (2)	NO331745B1 (el)
NZ (1)	NZ531945A (el)
PL (1)	PL210697B1 (el)
PT (1)	PT1436322E (el)
RU (1)	RU2337106C2 (el)
SI (1)	SI1436322T1 (el)
TN (1)	TNSN04069A1 (el)
UY (1)	UY27502A1 (el)
WO (1)	WO2003033527A2 (el)
ZA (1)	ZA200402270B (el)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI1436321T1 (sl)	2001-10-19	2006-12-31	Isotechnika Inc	Sinteza analogov ciklosporina
PT1436322E (pt) *	2001-10-19	2008-10-23	Isotechnika Inc	Misturas de análogos da ciclosporina e sua utilização como agentes imunomodulantes
US7538084B2 (en)	2003-03-17	2009-05-26	Amr Technology, Inc.	Cyclosporins
TW200505946A (en) *	2003-04-08	2005-02-16	Hoffmann La Roche	Process for preparation of cyclosporin a analog
US7511013B2 (en)	2004-09-29	2009-03-31	Amr Technology, Inc.	Cyclosporin analogues and their pharmaceutical uses
US7378391B2 (en)	2004-09-29	2008-05-27	Amr Technology, Inc.	Cyclosporin alkyne analogues and their pharmaceutical uses
EP1812037A4 (en)	2004-10-06	2009-11-11	Amr Technology Inc	ALKYNES OF CYCLOSPORINE AND THEIR USEFUL AS PHARMACEUTICAL AGENTS
MX2007007262A (es) *	2004-12-17	2007-10-19	Isotechnika Inc	Metabolitos de analogos de ciclosporina.
US7696166B2 (en)	2006-03-28	2010-04-13	Albany Molecular Research, Inc.	Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en)	2006-03-28	2010-04-13	Albany Molecular Research, Inc.	Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
MX2010003364A (es)	2007-10-08	2010-07-06	Lux Biosciences Inc	Composiciones oftalmicas que comprenden inhibidores de calcineurina o inhibidores de mtor.
WO2010144194A1 (en)	2009-06-09	2010-12-16	Lux Biosciences, Inc.	Topical drug delivery systems for ophthalmic use
GB0912584D0 (en) *	2009-07-20	2009-08-26	Ucl Business Plc	Cyclosporin conjugates
CN107496902B (zh)	2010-12-15	2022-01-18	康卓维尔制药公司	在氨基酸1和3位修改的环孢菌素类似分子
GB201222455D0 (en) *	2012-12-13	2013-01-30	Perioc Ltd	Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
EP3549051A4 (en) *	2016-11-30	2020-04-29	Schrodinger, Inc.	GRAPHIC USER INTERFACE FOR CALCULATING CHEMICAL TRANSITIONAL STATES
EP3551047A1 (en)	2016-12-07	2019-10-16	Progenity, Inc.	Gastrointestinal tract detection methods, devices and systems
WO2018106928A1 (en)	2016-12-08	2018-06-14	Contravir Pharmaceuticals, Inc.	Treatment and prevention of hbv diseases by cyclosporine analogue molecules modified at amino acides 1 and 3
EP3554346B1 (en)	2016-12-14	2024-01-31	Biora Therapeutics, Inc.	Treatment of a disease of the gastrointestinal tract with an immunosuppressant
US20190224275A1 (en)	2017-05-12	2019-07-25	Aurinia Pharmaceuticals Inc.	Protocol for treatment of lupus nephritis
US10286036B2 (en) *	2017-05-12	2019-05-14	Aurinia Pharmaceuticals Inc.	Protocol for treatment of lupus nephritis
US20230041197A1 (en)	2018-06-20	2023-02-09	Progenity, Inc.	Treatment of a disease of the gastrointestinal tract with an immunomodulator
EP4201952A1 (en)	2021-12-21	2023-06-28	Curia Spain, S.A.U.	Process for the controlled synthesis of voclosporin
WO2024052941A1 (en) *	2022-09-09	2024-03-14	Dr. Reddy's Laboratories Limited	Improved process for the preparation of voclosporin
IT202300001116A1 (it) *	2023-01-25	2024-07-25	Indena Spa	Processo per la preparazione di un intermedio utile per la sintesi di voclosporina
IT202300001056A1 (it) *	2023-01-25	2024-07-25	Procos Spa	Nuovo processo per la preparazione di voclosporina amorfa

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4278545A (en) *	1979-09-12	1981-07-14	The Bendix Corporation	Apparatus for separating solids and liquid components
CH670644A5 (el) *	1986-12-18	1989-06-30	Lonza Ag
US5162540A (en) *	1986-12-18	1992-11-10	Lonza Ltd.	Process for the production of (+) biotin
DE3884470T2 (de) *	1987-06-17	1994-03-10	Sandoz Ag	Cyclosporine und deren Benutzung als Arzneimittel.
US5972630A (en) *	1991-08-19	1999-10-26	Dade Behring Marburg Gmbh	Homogeneous immunoassays using enzyme inhibitors
US5750510A (en) *	1997-04-04	1998-05-12	Abbott Laboratories	3-descladinose-2,3-anhydroerythromycin derivatives
US5939406A (en) *	1997-07-21	1999-08-17	Wisconsin Alumni Research Foundation	18-substituted-19-nor-vitamin D compounds
DE69840586D1 (de) *	1997-10-08	2009-04-02	Isotechnika Inc	Deuterierte Cyclosporin-analoga und ihre Verwendung als immunmodulierende Agenzien
PT1436322E (pt) *	2001-10-19	2008-10-23	Isotechnika Inc	Misturas de análogos da ciclosporina e sua utilização como agentes imunomodulantes
SI1436321T1 (sl) *	2001-10-19	2006-12-31	Isotechnika Inc	Sinteza analogov ciklosporina

2002
- 2002-10-17 PT PT02767028T patent/PT1436322E/pt unknown
- 2002-10-17 IL IL16076202A patent/IL160762A0/xx unknown
- 2002-10-17 AU AU2002331510A patent/AU2002331510B2/en not_active Expired
- 2002-10-17 MX MXPA04003624A patent/MXPA04003624A/es active IP Right Grant
- 2002-10-17 PL PL370501A patent/PL210697B1/pl unknown
- 2002-10-17 KR KR1020047005721A patent/KR100992850B1/ko active IP Right Grant
- 2002-10-17 CA CA2727642A patent/CA2727642C/en not_active Expired - Lifetime
- 2002-10-17 EP EP07106871A patent/EP1816138A1/en not_active Withdrawn
- 2002-10-17 AT AT02767028T patent/ATE401339T1/de active
- 2002-10-17 SI SI200230742T patent/SI1436322T1/sl unknown
- 2002-10-17 ME MEP-2008-780A patent/ME00487B/me unknown
- 2002-10-17 EP EP02767028A patent/EP1436322B1/en not_active Expired - Lifetime
- 2002-10-17 NZ NZ531945A patent/NZ531945A/en not_active IP Right Cessation
- 2002-10-17 CN CNB02820798XA patent/CN100344648C/zh not_active Expired - Lifetime
- 2002-10-17 JP JP2003536265A patent/JP2005511538A/ja not_active Withdrawn
- 2002-10-17 UY UY27502A patent/UY27502A1/es not_active Application Discontinuation
- 2002-10-17 DE DE60227686T patent/DE60227686D1/de not_active Expired - Lifetime
- 2002-10-17 MY MYPI20023885A patent/MY187182A/en unknown
- 2002-10-17 CA CA2460685A patent/CA2460685C/en not_active Expired - Lifetime
- 2002-10-17 AR ARP020103918A patent/AR036853A1/es not_active Application Discontinuation
- 2002-10-17 RU RU2004110941/04A patent/RU2337106C2/ru active
- 2002-10-17 DK DK02767028T patent/DK1436322T3/da active
- 2002-10-17 ES ES02767028T patent/ES2310604T3/es not_active Expired - Lifetime
- 2002-10-17 BR BR0213659-7A patent/BR0213659A/pt not_active IP Right Cessation
- 2002-10-17 WO PCT/CA2002/001560 patent/WO2003033527A2/en active IP Right Grant
2004
- 2004-03-05 IL IL160762A patent/IL160762A/en active IP Right Grant
- 2004-03-23 ZA ZA2004/02270A patent/ZA200402270B/en unknown
- 2004-03-26 MA MA27598A patent/MA26337A1/fr unknown
- 2004-04-14 EC EC2004005061A patent/ECSP045061A/es unknown
- 2004-04-14 EC EC2004005059A patent/ECSP045059A/es unknown
- 2004-04-14 EC EC2004005060A patent/ECSP045060A/es unknown
- 2004-04-16 TN TNP2004000069A patent/TNSN04069A1/en unknown
- 2004-04-19 HR HRP20040353AA patent/HRP20040353B1/hr not_active IP Right Cessation
- 2004-04-19 CO CO04035672A patent/CO5570682A2/es not_active Application Discontinuation
- 2004-05-14 NO NO20042029A patent/NO331745B1/no not_active IP Right Cessation
- 2004-07-22 HK HK04105424A patent/HK1062567A1/xx not_active IP Right Cessation
2008
- 2008-10-13 CY CY20081101130T patent/CY1108410T1/el unknown
2009
- 2009-06-11 JP JP2009140608A patent/JP5272140B2/ja not_active Expired - Lifetime
2010
- 2010-07-02 JP JP2010151859A patent/JP2011006417A/ja active Pending
- 2010-12-23 US US12/977,602 patent/US20110092669A1/en not_active Abandoned
2013
- 2013-01-31 JP JP2013017448A patent/JP2013136597A/ja active Pending
2014
- 2014-03-18 US US14/217,827 patent/US20140288266A1/en not_active Abandoned
2022
- 2022-10-14 NL NL301200C patent/NL301200I2/nl unknown
- 2022-10-14 NO NO2022042C patent/NO2022042I1/no unknown
- 2022-10-14 CY CY2022030C patent/CY2022030I2/el unknown
- 2022-10-14 BE BE2022C547C patent/BE2022C547I2/nl unknown
- 2022-10-14 FR FR22C1051C patent/FR22C1051I2/fr active Active
- 2022-10-14 LT LTPA2022521C patent/LTC1436322I2/lt unknown
- 2022-10-14 FI FIC20220041C patent/FIC20220041I1/fi unknown

Also Published As

Publication number	Publication date
JP2013136597A (ja)	2013-07-11
ECSP045059A (es)	2004-07-23
IL160762A (en)	2010-11-30
MA26337A1 (fr)	2004-10-01
ECSP045060A (es)	2004-07-23
TNSN04069A1 (en)	2006-06-01
EP1436322A2 (en)	2004-07-14
CA2460685C (en)	2014-05-27
MY187182A (en)	2021-09-08
UY27502A1 (es)	2003-04-30
FR22C1051I2 (fr)	2023-11-17
WO2003033527A3 (en)	2003-10-16
WO2003033527A2 (en)	2003-04-24
DK1436322T3 (da)	2008-11-03
NO331745B1 (no)	2012-03-19
CA2727642A1 (en)	2003-04-24
JP2009197036A (ja)	2009-09-03
US20110092669A1 (en)	2011-04-21
KR100992850B1 (ko)	2010-11-09
ZA200402270B (en)	2005-05-25
FR22C1051I1 (fr)	2022-12-16
FIC20220041I1 (fi)	2022-10-14
US20140288266A1 (en)	2014-09-25
CA2460685A1 (en)	2003-04-24
AU2002331510B2 (en)	2008-05-01
NZ531945A (en)	2006-01-27
NO2022042I1 (no)	2022-10-14
LTPA2022521I1 (el)	2022-11-10
JP2005511538A (ja)	2005-04-28
BE2022C547I2 (el)	2022-10-19
PL210697B1 (pl)	2012-02-29
HRP20040353A2 (en)	2005-04-30
CY2022030I1 (el)	2023-01-27
HRP20040353B1 (hr)	2012-10-31
RU2004110941A (ru)	2005-08-10
PL370501A1 (en)	2005-05-30
NO20042029L (no)	2004-05-14
SI1436322T1 (sl)	2008-12-31
CN100344648C (zh)	2007-10-24
RU2337106C2 (ru)	2008-10-27
EP1436322B1 (en)	2008-07-16
EP1816138A1 (en)	2007-08-08
CO5570682A2 (es)	2005-10-31
ECSP045061A (es)	2004-08-27
DE60227686D1 (de)	2008-08-28
CA2727642C (en)	2014-02-04
PT1436322E (pt)	2008-10-23
CN1571794A (zh)	2005-01-26
ATE401339T1 (de)	2008-08-15
ES2310604T3 (es)	2009-01-16
MXPA04003624A (es)	2004-12-06
JP5272140B2 (ja)	2013-08-28
IL160762A0 (en)	2004-08-31
ME00487B (me)	2011-10-10
CY1108410T1 (el)	2012-05-23
HK1062567A1 (en)	2004-11-12
AR036853A1 (es)	2004-10-06
KR20050037421A (ko)	2005-04-21
LTC1436322I2 (el)	2023-06-26
NL301200I2 (nl)	2024-07-25
BR0213659A (pt)	2004-10-26
JP2011006417A (ja)	2011-01-13

Publication	Publication Date	Title
CY2022030I2 (el)	2023-06-09	Μειγματα αναλογων κυκλοσπορινης και η χρηση τους ως ανοσορρυθμιστικοι παραγοντες
EP1636250A4 (en)	2010-11-03	SELF-ORGANIZING PEPTIDES CONTAINING MODIFICATIONS AND METHOD FOR THEIR USE
AU7007001A (en)	2002-01-02	Nitrosated and nitrosylated taxanes, compositions and methods of use
DE60138711D1 (de)	2009-06-25	Antikörper gegen il-12, zusammensetzungen, verfahren und verwendungen
DE60229061D1 (de)	2008-11-06	Herstellung und verwendung von nanopartikel
DE60310912D1 (de)	2007-02-15	Waschmittelzusammensetzungen und komponenten davon
BRPI0208558A2 (pt)	2017-05-23	preparado de combinação de estrogênio-gestagênio e uso
DE60126814D1 (de)	2007-04-05	Inhalation von stickoxid
DK1558595T3 (da)	2010-03-29	Piperazinyl- og diazapanylbenzamider og -benzthioamider
EP1476159A4 (en)	2006-03-01	9-NITROCAMPTOTHECIN POLYMORPHIC COMPOSITIONS AND FORMULATIONS AND METHODS OF USING THE SAME
DE60236391D1 (de)	2010-07-01	Turbine und Turbinenschaufel
DE60304223D1 (de)	2006-05-11	Herstellung von metallamid-komplexen
DE60132362D1 (de)	2008-02-21	Herstellung von ultradünnwandigen cordierit-strukturen
DE60238174D1 (de)	2010-12-16	Fluoropolymere und Herstellungs- und Verwendungsverfahren
DE602004022046D1 (de)	2009-08-27	Herstellung von kleinen teilchen
DE60333439D1 (de)	2010-09-02	Herstellung von olefinen
EP1461450A4 (en)	2008-04-02	T-BET COMPOSITIONS AND METHOD OF USE THEREOF
DE602004013599D1 (de)	2008-06-19	Herstellung von somatostatinpeptiden
DE60307022D1 (de)	2006-09-07	Herstellung von Organohalosilanen
DE60323960D1 (de)	2008-11-20	Enzen 900 und 1800 mhz
ITTO20020684A0 (it)	2002-07-31	Nuovo uso dell'angelicina e di suoi analoghi strutturali
DE60109730D1 (de)	2005-05-04	Zementzusatzmittel und Zementzusammensetzung
DE50106970D1 (de)	2005-09-08	Turbinenschaufel und Turbine
DE60227607D1 (de)	2008-08-28	Spielsystem und Spielprogramm
DE50210561D1 (de)	2007-09-06	Sitz- und/oder liegemöbel